Acute Anterior Uveitis: Psychic Burden and Pain

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2011 by Hospital Hietzing.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Medical University of Graz
Information provided by (Responsible Party):
Saskia M Maca, Hospital Hietzing
ClinicalTrials.gov Identifier:
NCT01156285
First received: July 1, 2010
Last updated: November 27, 2011
Last verified: November 2011
  Purpose

Acute anterior uveitis (AU) is a common reason for attendance at ophthalmic outpatient clinics. The painfulness and the fear of a transient or even persistent loss of vision may markedly reduce the individual's subjective well-being and pose a psychological burden.

This study will test the hypothesis that during an attack of AU the patient experiences a marked reduction in psychological and physical well-being.

Prospective, hospital-based epidemiologic study using a patient questionnaire with standardized psychological tests and a pain scale.


Condition Intervention
Anterior Uveitis
Other: Filling in a patient questionnaire

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Acute Anterior Uveitis: Psychic Burden and Pain

Resource links provided by NLM:


Further study details as provided by Hospital Hietzing:

Estimated Enrollment: 35
Study Start Date: May 2010
Estimated Study Completion Date: June 2012
Groups/Cohorts Assigned Interventions
AAU
patient with acute attack of anterior uveitis
Other: Filling in a patient questionnaire
Filling in a patient questionnaire

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients with acute attack of anterior uveitis

Criteria

Inclusion Criteria:

  • Acute attack of anterior uveitis

Exclusion Criteria:

  • Other forms of uveitis
  • Chronic anterior uveitis
  • Therapy started
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01156285

Contacts
Contact: Saskia M Maca, MD +43-1-80110 ext 2266 Saskia.Maca@wienkav.at

Locations
Austria
Department of Ophthalmology, Medical University Graz Not yet recruiting
Graz, Styria, Austria
Contact: Andreas Wedrich, MD, Prof.    43-316-385 ext 2394      
Principal Investigator: Andreas Wedrich, MD, Prof         
Sub-Investigator: Julia Wagner, MD         
Department of Ophthalmology, Hietzing Hospital Recruiting
Vienna, Austria, 1130
Principal Investigator: Saskia M Maca, MD         
Sponsors and Collaborators
Hospital Hietzing
Medical University of Graz
Investigators
Study Director: Saskia M Maca, MD Hospital Hietzing
  More Information

No publications provided

Responsible Party: Saskia M Maca, MD, Hospital Hietzing
ClinicalTrials.gov Identifier: NCT01156285     History of Changes
Other Study ID Numbers: MAC110
Study First Received: July 1, 2010
Last Updated: November 27, 2011
Health Authority: Austria: Ethics committee of the city of Vienna

Additional relevant MeSH terms:
Uveitis
Chorioretinitis
Uveitis, Anterior
Iridocyclitis
Uveal Diseases
Eye Diseases
Retinitis
Retinal Diseases
Choroiditis
Choroid Diseases
Uveitis, Posterior
Panuveitis
Iris Diseases

ClinicalTrials.gov processed this record on April 15, 2014